The High Court has granted special leave to a cosmetic company to challenge a judgment finding it infringed Botox maker Allergan’s trade marks by marketing its topical creams as Botox alternatives.
Cotton On has settled court proceedings brought against rival surf and streetwear label Ghanda for threatening it with a copyright and trade mark infringement lawsuit.
Two of the world’s largest manufacturers of explosives have taken their fight over three patents for a detonation device to the Federal Court.
The High Court has rejected plumbing company Repipe’s application to hear its case centred on the question of patent eligibility for computer-implemented inventions, saying the case was not an appropriate vehicle for special leave.
Pharmaceutical giant Pfizer has fired off a lawsuit against four drug companies for allegedly infringing one of its patents for biologic Enbrel by selling a biosimilar of the blockbuster arthritis drug in Australia.
Bayer has dropped its appeal to a ruling that quashed an extension for its patent covering an oral contraceptive, after the Full Court dealt drug makers a blow in two separate cases on how patent term extensions should be calculated.
Discount pharmacy Priceline cannot trade mark the signature bright pink that adorns it shopfront signs and awnings, an IP Australia delegate has found.
Apple is “unlikely” to avoid production of the source code for its Touch ID and Face ID technology to an Australian non-practicing entity that has sued the Silicon Valley company for patent infringement, a judge has said.
Mining tool company Globaltech has lost its bid to delay Australian Mud Company’s case, on foot since 2016, which seeks $39.9 million in damages for its rival’s infringement of a mining tool patent.
The maker of Mother brand energy drinks has won a stay of a judge’s decision to remove one of its trade marks for non-use, but has been hit with indemnity costs in its ongoing intellectual property stoush with rival Cantarella Bros.